References for Altering the Course
By Carey Marie Boehm, NP, and Sheila Smith, NP, PhD
Volume 3, Issue 5
Pp. 69 - 73
1. American Diabetes Association. The prevention or delay of type 2 diabetes. Diabetes Care. 2002;25:742-749.
2. American Diabetes Association. Pre-diabetes. Available at: http://www.diabetes.org/pre-diabetes.jsp. Accessed Aug. 17, 2007.
3. Meigs JB. The metabolic syndrome (insulin resistance syndrome or syndrome X). Up to Date. Available with paid subscription at: www.utdol.com. 2005;13(2). Accessed Aug. 17, 2007.
4. Engelgau M, et al. Screening for type 2 diabetes. Diabetes Care. 2000;23(10):1563-1580.
5. Harris M, et al. Onset of NIDDM occurs at least 4 to 7 years before clinical diagnosis. Diabetes Care. 1992;15(7):815-819.
6. Jarret RJ. Duration of non-insulin dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabetic Med. 1986;3:261-63.
7. Kanaya AM, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care. 2005;28(2):404-408.
8. Lemieux S. Contribution of visceral obesity to insulin resistance syndrome. Can J Applied Physiol. 2001;26:273-290.
9. Utzschneider KM, et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes. 2004;53(11):2867-2872.
10. Arslanian SA, et al. Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin clearance and its relationship to insulin sensitivity. Diabetes. 2002;51:3014-3019.
11. Gower BA, et al. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes. 2003;52(4):1047-1051.
12. McCulloch DK, Robertson RP. Prediction and prevention of type 2 diabetes mellitus. Up to Date. Available with paid subscription at: www.utdol.com. 2005;13(2). Accessed Aug. 17, 2007.
13. Weinstein AR, et al. Relationship of physical activity vs. body mass index with type 2 diabetes in women. JAMA. 2004;292(10):1188-1194.
14. Must A, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523-1529.
15. Gallagher D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol. 1996;143(3):228-239.
16. Ferreira I, et al. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of metabolic syndrome in young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165(1):42-48.
17. Edelstein SL, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46(4):701-710.
18. Stern MP, et al. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575-581.
19. Stolk RP, Orchard TJ. Why use the oral glucose tolerance test? Diabetes Care. 1995;18(7):1045-1049.
20. Gabir M, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23(8):1108-1112.
21. Pan XR, et al. The effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care. 1997;20(4):537-544.
22. Toumilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subject with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350.
23. The Diabetes Prevention Research Group: Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med. 2002;346:393-403.
|